| Gene symbol | FAP | Synonyms | DPPIV, FAPA, FAPalpha, SIMP | Type of gene | protein-coding | |
| Chromosome | 2 | Map location | 2q24.2 | dbXrefs | Entrez:2191 MIM:600403 HGNC:HGNC:3590 Ensembl:ENSG00000078098 AllianceGenome:HGNC:3590 | |
| Gene perturbation-related omics dataset | PerturbAtlas | |||||
| Description | fibroblast activation protein alpha | |||||
| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding | |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | Entrez:22914 MIM:611817 HGNC:HGNC:18788 Ensembl:ENSG00000213809 AllianceGenome:HGNC:18788 | |
| Gene perturbation-related omics dataset | PerturbAtlas | |||||
| Description | killer cell lectin like receptor K1 | |||||
| Gene symbol | FOLH1 | Synonyms | FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM, PSMA, mGCP | Type of gene | protein-coding | |
| Chromosome | 11 | Map location | 11p11.12 | dbXrefs | Entrez:2346 MIM:600934 HGNC:HGNC:3788 Ensembl:ENSG00000086205 AllianceGenome:HGNC:3788 | |
| Description | folate hydrolase 1 | |||||
| GTO ID | GTC1021 |
| Trial ID | ChiCTR2300073645 |
| Disease | Multiple Myeloma |
| Altered gene | PSMA|NKG2D|FAP |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | PSMA/NKG2DL/FAP TCR-T cells |
| HLA | HLA-independent |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A prospective study of the BCMA/NKG2DL/FAP-targeted HLA-independent TCR-T cells therapy for refractory/relapsed multiple myeloma |
| Year | 2023 |
| Country | China |
| Company sponsor | The First People's Hospital of Foshan |
| Cohort 1 | |||||
|
|||||